![Kristen Laguerre](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kristen Laguerre
Directeur Financier/CFO chez
MPM BioImpact LLC
Profil
Kristen Laguerre, an accomplished operating executive, is Managing Director, Chief Financial Officer and Chief Operating Officer at MPM BioImpact.
With over 20 years of financial leadership and management experience in the venture capital industry, her primary responsibility is to oversee the firm’s finance, operations and administrative functions.
Kristen is also an investment committee member of the Oncology Impact Funds, private/public funds focused on oncology as well as new modalities.
Kristen is currently serving as interim CFO at portfolio company ReNAgade Therapeutics and was previously CFO at portfolio company Cullinan Oncology (NASDAQ: CGEM).
Prior to joining MPM BioImpact, Kristen served as Partner and CFO at Flare Capital Partners, and, previously, Partner and CFO at Atlas Venture, an early-stage life sciences and technology venture capital firm, where she was responsible for finance, operations and administration.
Before Atlas Venture, she was Vice President – Finance at Softbank Capital, where she was responsible for finance, human resources and operations associated with both Softbank’s venture funds and its global activities outside of East Asia.
Earlier in her career, Kristen spent seven years at Arthur Andersen LLP.
Widely recognized in the private equity industry, Kristen is a board member of Financial Executives Alliance, a steering committee member of Women in Alternative Assets and previously served as a board member of the Private Equity CFO Association.
Kristen earned her M.B.A. in Finance and Accounting from Boston University and her B.A. in Economics from Wesleyan University.
Postes actifs de Kristen Laguerre
| Sociétés | Poste | Début |
|---|---|---|
MPM BioImpact LLC
 MPM BioImpact LLC Investment ManagersFinance MPM Capital invests in both public and private companies located in the United States. The firm targets companies operating in the fields of biotechnology, healthcare and life science sectors. It participates in early stage capital transactions. | Directeur Financier/CFO | 01/08/2019 |
Anciens postes connus de Kristen Laguerre
| Sociétés | Poste | Fin |
|---|---|---|
| CULLINAN THERAPEUTICS, INC. | Directeur Financier/CFO | 02/08/2019 |
Atlas Venture Advisors, Inc.
 Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors invests in companies located in the United States. The firm focuses on life sciences and biotech sectors. It provides financing for early stage capital requirements. | Directeur Général | 02/01/2014 |
SoftBank Capital Partners LLC
 SoftBank Capital Partners LLC Investment ManagersFinance SoftBank Capital Partners seeks investment opportunities in companies located in the United States. The firm targets companies operating in the fields of content, applications and technology-based services. It provides financing for seed, early and later stage capital requirements. It takes a seat on the board of directors. | Directeur Financier/CFO | 31/12/2006 |
Reunion Neuroscience, Inc.
 Reunion Neuroscience, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops FDA-approved serotonergic psychedelic therapeutic solutions for underserved mental health disorders | Directeur/Membre du Conseil | - |
Flare Capital Management Co. LLC
 Flare Capital Management Co. LLC Investment ManagersFinance Flare Capital Management invests in companies located in the United States. The firm targets companies operating in the fields of the healthcare technology sectors. It provides financing for early to growth stage capital transactions. | Directeur Financier/CFO | - |
Formation de Kristen Laguerre
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
58
Relations au 1er degré
10
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
SoftBank Capital Partners LLC
SoftBank Capital Partners LLC Investment ManagersFinance SoftBank Capital Partners seeks investment opportunities in companies located in the United States. The firm targets companies operating in the fields of content, applications and technology-based services. It provides financing for seed, early and later stage capital requirements. It takes a seat on the board of directors. | Finance |
MPM BioImpact LLC
MPM BioImpact LLC Investment ManagersFinance MPM Capital invests in both public and private companies located in the United States. The firm targets companies operating in the fields of biotechnology, healthcare and life science sectors. It participates in early stage capital transactions. | Finance |
Boston University
 Boston University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Arthur Andersen LLP
 Arthur Andersen LLP Miscellaneous Commercial ServicesCommercial Services Provides accounting services | Commercial Services |
Atlas Venture Advisors, Inc.
Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors invests in companies located in the United States. The firm focuses on life sciences and biotech sectors. It provides financing for early stage capital requirements. | Finance |
Wesleyan University
 Wesleyan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Spero Therapeutics, Inc.
 Spero Therapeutics, Inc. BiotechnologyHealth Technology Develops therapies for the treatment of bacterial infections | Health Technology |
Flare Capital Management Co. LLC
Flare Capital Management Co. LLC Investment ManagersFinance Flare Capital Management invests in companies located in the United States. The firm targets companies operating in the fields of the healthcare technology sectors. It provides financing for early to growth stage capital transactions. | Finance |
Cullinan Oncology, Inc.
 Cullinan Oncology, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Reunion Neuroscience, Inc.
Reunion Neuroscience, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops FDA-approved serotonergic psychedelic therapeutic solutions for underserved mental health disorders | Health Technology |
